ATE138579T1 - Verwendung von enzymen - Google Patents

Verwendung von enzymen

Info

Publication number
ATE138579T1
ATE138579T1 AT91302396T AT91302396T ATE138579T1 AT E138579 T1 ATE138579 T1 AT E138579T1 AT 91302396 T AT91302396 T AT 91302396T AT 91302396 T AT91302396 T AT 91302396T AT E138579 T1 ATE138579 T1 AT E138579T1
Authority
AT
Austria
Prior art keywords
enzyme
link
enzymes
hypohalite
peroxidase
Prior art date
Application number
AT91302396T
Other languages
German (de)
English (en)
Inventor
Thomas Stewart Beggs
Paul James Davis
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909006329A external-priority patent/GB9006329D0/en
Priority claimed from GB909021671A external-priority patent/GB9021671D0/en
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE138579T1 publication Critical patent/ATE138579T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
AT91302396T 1990-03-21 1991-03-20 Verwendung von enzymen ATE138579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909006329A GB9006329D0 (en) 1990-03-21 1990-03-21 Cell killing
GB909021671A GB9021671D0 (en) 1990-10-05 1990-10-05 Delivery of agents

Publications (1)

Publication Number Publication Date
ATE138579T1 true ATE138579T1 (de) 1996-06-15

Family

ID=26296816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91302396T ATE138579T1 (de) 1990-03-21 1991-03-20 Verwendung von enzymen

Country Status (8)

Country Link
EP (1) EP0451972B1 (oth)
JP (1) JPH0584073A (oth)
AT (1) ATE138579T1 (oth)
AU (1) AU642980B2 (oth)
CA (1) CA2038579C (oth)
DE (1) DE69119817T2 (oth)
ES (1) ES2088463T3 (oth)
IN (1) IN172887B (oth)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680407B2 (en) * 1992-03-06 1997-07-31 Creagen, Inc. Pathogen-targeted biocatalyst
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
US5665333A (en) * 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
EP0868199A1 (en) * 1995-12-21 1998-10-07 Quest International B.V. Particle compositions
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
US9034329B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
ATE511543T1 (de) 1999-02-22 2011-06-15 Univ Georgetown Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
AU7648900A (en) * 1999-09-16 2001-04-17 Unilever Plc Delivery system for antidandruff agent
FR2803199B1 (fr) * 1999-12-29 2002-05-10 Jean Dominique Dana Procede de transformation des sucres alimentaires cariogenes en produits neutres acariogenes ou cariostatiques et composition pour la mise en oeuvre
DE60228842D1 (de) * 2001-04-02 2008-10-23 Univ Georgetown Vereinfachtes und verbessertes verfahren zur herstellung eines antikörper- oder antikörperfragment-targeted immunoliposoms oder polyplex für die systemische verabreichung eines therapeutischen oder diagnostischen mittels
AU2006303649B2 (en) * 2005-10-21 2013-02-28 Dupont Nutrition Biosciences Aps A composition comprising a coupled enzyme system
MX2008014362A (es) 2006-05-15 2008-11-27 Univ Georgetown Preparacion de inmunoliposomas dirigidos a anticuerpos o a fragmentos de anticuerpos para la administracion sistemica de agentes terapeuticos o de diagnostico y usos de los mismos.
CA2822422C (en) 2010-12-20 2021-02-02 E. I. Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578265A (en) * 1981-08-13 1986-03-25 Laclede Professional Products, Inc. Di-enzymatic dentifrice
IL83567A (en) * 1986-08-18 1992-02-16 Dow Chemical Co Starburst conjugates with a carried material,such as an agricultural or pharmaceutical material
WO1990003185A1 (en) * 1988-09-28 1990-04-05 Ideon Corporation Combination enzyme immunotherapeutics
WO1991000112A1 (en) * 1989-06-30 1991-01-10 Brunswick Corporation Antibody-lactate oxidase conjugates
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
AU5544090A (en) * 1990-04-26 1991-11-11 Ringdal Patenter A/S Activating unit for weapon

Also Published As

Publication number Publication date
IN172887B (oth) 1993-12-25
JPH0584073A (ja) 1993-04-06
AU7299791A (en) 1991-10-03
ES2088463T3 (es) 1996-08-16
EP0451972A1 (en) 1991-10-16
DE69119817D1 (de) 1996-07-04
DE69119817T2 (de) 1996-10-31
EP0451972B1 (en) 1996-05-29
AU642980B2 (en) 1993-11-04
CA2038579A1 (en) 1991-09-22
CA2038579C (en) 1998-06-23

Similar Documents

Publication Publication Date Title
DE69119817D1 (de) Verwendung von Enzymen
DE69428290D1 (de) Derivate von alpha-hordothionin mit höherem behalt an lysin
DE3876050D1 (de) Okulare hypotensivagenzien.
ES2107447T3 (es) Ftalidas substituidas y ftalidas heterociclicas.
ATE239094T1 (de) Behandlung von amplifizierter dns mit alkalischer phosphatase
NO2013009I1 (no) Alipogen tiparvovec
ES2130232T3 (es) N,n'-diacilhidrazinas n' sustituidas como insecticidas.
EP0675904A4 (en) HUMANE NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE VIRUS FROM HUMAN THAT MAKES THE IMMUNE.
ES2164731T3 (es) Suspension acuosa tixotropica de agentes fitoprotectores.
NO864569D0 (no) Modifiserte fibrinolyttiske midler.
GR852493B (oth)
DE3870284D1 (de) Mikrobenbekaempfungsmittel.
TR199701576T1 (xx) N-aril-1,2,4,-triazolin-5-onlar.
ATE93540T1 (de) Menschliche pankreaselastase i.
DK0630408T3 (da) Fremstilling af $i(Aspergillus niger catalase-R)
ES2058141T3 (es) Utilizacion de gamma-glutamil-transpeptidasa.
DE69120452D1 (de) Verwendung und Verabreichung von Enzymen
ATE55990T1 (de) Substituierte 4,6-alkoxypyridincarboxylatverbindungen.
DK44185D0 (da) Stabiliseret enzymkonjugat
TNSN89009A1 (fr) Utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
DE3464599D1 (de) Alpha-allenic-alpha-amino acids
ATE177526T1 (de) Hubbalkenofen
NO903506D0 (no) Distraksjonsapparat for aa opprettholde orientering av brukket ledd.